ALL |
Acute lymphoblastic leukemia |
B-ALL |
Acute lymphoblastic leukemia |
ADC |
Adenocarcinoma |
ATP |
Adenosine triphosphate |
ADV |
Adenovirus |
ADCC |
Antibody-dependent cell-mediated cytotoxicity |
AO-1 |
Atractylenolide I |
BCG |
Bacillus Calmette–Guerin |
BE |
Barrett’s esophagus |
B-CLL |
B-cell chronic lymphocytic leukemia |
BCPALL |
B-cell precursor acute lymphoblastic leukemia |
BBMC |
Bone marrow mononuclear cells |
BLS |
Brucella lumazine synthase |
BL |
Burkitt lymphoma |
cagPAI |
cag pathogenicity island |
CSC |
Cancer stem cells |
CAF |
Cancer-associated fibroblasts |
CD40L |
CD40 ligand |
CLL |
Chronic lymphocytic leukemia |
CRC |
Colorectal cancers |
CXCR3 |
C-X-C Motif Chemokine Receptor 3 |
COX-2 |
Cyclo-oxygenase 2 |
DAMPs |
Damage/danger-associated molecular patterns |
DNMT2 |
DNA methyltransferase 2 |
dsRNA |
Double-stranded RNA |
EGF |
Epidermal growth factor |
EAC |
Esophageal adenocarcinoma |
ESCC |
Esophageal squamous cell carcinomas |
EMA |
European Medicine Agency |
FGF2 |
Fibroblast growth factor 2 |
FOXP3 |
Forkhead box P3 |
GC |
Gastric cancer |
GB |
Glioblastoma |
GSCs |
Glioma stem cells |
HBV |
Hepatitis B virus |
HCV |
Hepatitis C virus |
HCC |
Hepatocellular carcinoma |
HL |
Hodgkin’s lymphoma |
HIV |
Human immunodeficiency virus |
HPV |
Human papillomavirus |
hTLRs |
Human TLRs |
IKBKG |
Inhibitor of NF-κB kinase-γ |
IRF-3 |
Interferon regulatory factor-3 |
IL-1β |
Interleukin |
IARC |
International Agency for Research on Cancer |
LRR |
Leucine-rich repeats |
LPS |
Lipopolysaccharide |
MCL |
Mantle cell lymphoma |
MMP9 |
Matrix-metalloproteinase 9 |
MAMPs |
Microbial/microbe-associated molecular patterns |
miRNAs |
MicroRNAs |
MAPKs |
Mitogen-activated protein kinase |
MPLA |
Monophosphoryl lipid A |
MM |
Multiple myeloma |
MAL |
MyD88 adapter-like |
MyD88 |
Myeloid differentiation factor 88 |
MDSC |
Myeloid-derived suppressor cells |
NKAP |
NF-κB activating protein |
NLPHL |
Nodular lymphocyte predominant form |
NAFLD |
Non-alcoholic fatty liver disease |
NHL |
Non-Hodgkin’s lymphoma |
NSCLC |
Non-small cell lung cancer |
NF-κB |
Nuclear factor-κB |
NA |
Nucleic acid |
NAS |
Nucleic acid-sensing |
PAE |
Paeonol |
PDAC |
Pancreatic ductal adenocarcinoma |
PAMPs |
Pathogen-associated molecular patterns |
PRR |
Pattern recognizing receptors |
PBMC |
Peripheral blood mononuclear cells |
pDCs |
Plasmacytoid dendritic cells |
Poly I:C |
Polyriboinosinic-polyribocytidynic acid |
ROS |
Reactive oxygen species |
T reg cells |
Regulatory T |
SLE |
Systemic lupus erythematosus |
TH1 |
T helper 1 |
TTFT |
Time to first treatment |
TIRAP |
TIR domain-containing adapter protein |
TRIF |
TIR-domain-containing adapter-inducing interferon-β |
TLRs |
Toll like receptors |
TGF-β |
Transforming growth factor-β |
TRAM |
TRIF-related adaptor molecule |
TME |
Tumor microenvironment |
TNF-α |
Tumor necrosis factor-α |
MT1-MMP |
Type 1 matrix-bound metalloproteinase |
VEGF |
Vascular endothelial growth factor |
WHO |
World Health Organization |
XAMPs |
Xenobiotic-associated molecular patterns |